T3 · Product exporter position

France exports of Medicaments: containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale (HS 300460)

See where France stands in medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, packaged for retail sale: export scale, destination breadth, market position, growth, and reported trade history.

Exporter FRAHS6 300460Latest year 2024Rapid decline

Latest exports

$105.7MLatest observed lane total

Destination markets

56Reported active markets

Three-year growth

-33.4%Annualized change

Destination HHI

3,947Destination concentration

Weighted share

16.4%Reported market position

Exporter evidence

How strong is France in Medicaments: containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail sale?

Reported exporter totals and calculated indicators for HS 300460. Values retain their observed coverage period.

Exporter scale

Latest exports$105.7M
Current 2024 exports$24.8M
Three-year average$20.3M
Historical peak$1.1B

Market position

Active destinations56
Destination HHI3,947
Weighted share16.4%
Share change+0.9 pp

Competitiveness

Three-year growth-33.4%
Volatility0.8
Maximum drawdown70.2%
TrendRapid decline
MeasureValueWhat it describes
ExporterFranceCountry represented by this profile
Latest observed exports$105.7MSum of latest observed destination-lane values
Current 2024 exports$24.8MCommon-year comparison where reported
Three-year growth-33.4%Annualized change in exporter totals
Five-year growth-16.3%Annualized change in exporter totals
Leading destinationUKRDestination with the largest observed export value
Leading destination share61.8%Share of observed exporter totals
Destination concentration3,947HHI across destination markets
Weighted share change+0.9 ppValue-weighted latest change in market share
Limited-history lanes10.3%Share of lanes with shorter history

Destination markets

Where does France sell medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, packaged for retail sale?

Leading destination observations ranked by reported export value, with market position and access context.

DestinationLatest exportsMarket shareGrowthAccessSignal
Democratic Republic of the Congo$4.6M19.5%+253.7%Not reportedAccelerating
Nigeria$4.3M7.1%+219.8%0.3% tariffAccelerating
Côte d\'Ivoire$4.0M23.5%+4.2%FTA reportedGrowing
Niger$856.6K5.5%+10%0.1% tariffGrowing
United Rep. of Tanzania$432.7K3.7%-14.4%0.2% tariffGrowing
Sweden$415.6K0.6%+84%FTA reportedStable
Angola$91.1K0.6%-25.6%0.1% tariffStable

Destination

Democratic Republic of the Congo

Latest exports
$4.6M
Market share
19.5%
Growth
+253.7%
Access
Not reported
Signal
Accelerating

Destination

Nigeria

Latest exports
$4.3M
Market share
7.1%
Growth
+219.8%
Access
0.3% tariff
Signal
Accelerating

Destination

Côte d\'Ivoire

Latest exports
$4.0M
Market share
23.5%
Growth
+4.2%
Access
FTA reported
Signal
Growing

Destination

Niger

Latest exports
$856.6K
Market share
5.5%
Growth
+10%
Access
0.1% tariff
Signal
Growing

Destination

United Rep. of Tanzania

Latest exports
$432.7K
Market share
3.7%
Growth
-14.4%
Access
0.2% tariff
Signal
Growing

Destination

Sweden

Latest exports
$415.6K
Market share
0.6%
Growth
+84%
Access
FTA reported
Signal
Stable

Destination

Angola

Latest exports
$91.1K
Market share
0.6%
Growth
-25.6%
Access
0.1% tariff
Signal
Stable

Price intelligence

How does France's price position vary?

Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.

Highest reported price

Spain: $5.1M / ton.

Lowest reported price

Germany: $103.2 / ton.

Median price

$97.5K / ton across reported markets.

Export trend

Reported export history

Annual observations for France and HS 300460 where available.

YearExportsYear-on-year changeActive destinations
2010$351.8M-19.2%103
2011$378.5M+7.6%105
2012$458.8M+21.2%102
2013$432.9M-5.6%105
2014$323.8M-25.2%103
2015$258.4M-20.2%106
2016$324.0M+25.4%103
2017$951.5M+193.7%84
2018$468.8M-50.7%77
2019$60.3M-87.1%63
2020$54.0M-10.5%71
2021$84.1M+55.9%59
2022$16.2M-80.7%58
2023$19.8M+22%56
2024$24.8M+25.3%56

Exporter context

France economy and trade network

The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300460.

France has reported exports of $635.3B and a trade balance of -$95.5B in 2024.

Available structural indicators include 42.5% trade openness, 23.5% investment, and 270 active trade partners.

Reported values

Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.

Calculated indicators

Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.

Coverage

Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.

Frequently asked questions

Questions about France medicaments: containing antimalarial active principles described in subheading note 2 to this chapter, for therapeutic or prophylactic uses, packaged for retail sale exports

Quick answers based on the figures and coverage shown on this page.

How strong is this exporter?

Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.

Which markets are most important?

The destination table ranks reported markets by the latest observed export value.

Does the price section show quotes?

No. It summarizes reported trade value and quantity observations converted to unit values.

What should be checked next?

Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.